Gloria A. Cheung, NP
Nurse Practitioner · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Mindful Health Solutions A Professional Medical Corporation · 55 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Gloria A. Cheung’s office at (844) 867-8444 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$30,530
Medicare paid this office $30,530 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 63 · 85 and older 0% · Health risk score 1.06. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $115,442, Medicare allowed $38,481 and paid $30,530; for 53 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$5,978
Pharmacies billed $5,978 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 161) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
154 generic and fewer than 11 brand-name prescriptions · $5,978 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 18 | $2,366 | $131 |
| Bupropion Xl | 12 | $620 | $52 |
| Duloxetine | 22 | $428 | $19 |
| Alprazolam | 13 | $45 | $3 |
Year by year
| 2024 | 161 | 23 | 0% (0) | None | $5,978 |
| 2023 | 108 | 15 | 0% (0) | 19% | $11,710 |
| 2022 | 50 | None | 0% (0) | 0% | $1,789 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Bupropion Xl | 11 | $203 | $18 |
| Lamotrigine | 12 | $124 | $10 |
| Alprazolam | 11 | $37 | $3 |
Money from drug and device companies
$714 in 2025
| 2025 | 9 | 25 | None | $714 |
| 2024 | 4 | 12 | None | $297 |
| 2023 | 4 | 4 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lundbeck | Rexulti | $118 | 4 payments
|
| Janssen Pharmaceuticals | Spravato | $115 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $89 | 3 payments
|
| Abbvie | Vraylar | $88 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $81 | 3 payments
|
| Axsome Therapeutics | Auvelity | $63 | 2 payments
|
See all 25 published payments
| Alkermes | Meals · 2025-12-10 | Aristada | $26 |
| Neurocrine BioSciences | Meals · 2025-11-12 | Ingrezza | $26 |
| Abbvie | Meals · 2025-11-06 | Vraylar | $27 |
| Axsome Therapeutics | Meals · 2025-11-04 | Auvelity | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-28 | Caplyta | $32 |
| Otsuka America Pharmaceutical | Meals · 2025-10-23 | Rexulti | $34 |
| Janssen Pharmaceuticals | Meals · 2025-10-08 | Spravato | $24 |
| Neurocrine BioSciences | Meals · 2025-09-10 | Ingrezza | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-09-09 | Rexulti | $15 |
| Axsome Therapeutics | Meals · 2025-08-21 | Auvelity | $31 |
| Janssen Pharmaceuticals | Meals · 2025-08-20 | Spravato | $32 |
| Otsuka America Pharmaceutical | Meals · 2025-07-29 | Rexulti | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-10 | Caplyta | $29 |
| Alkermes | Meals · 2025-07-09 | Aristada | $23 |
| Lundbeck | Meals · 2025-06-13 | Rexulti | $28 |
| Abbvie | Meals · 2025-04-19 | Vraylar | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-16 | Cobenfy | $34 |
| Lundbeck | Meals · 2025-04-10 | Rexulti | $31 |
| Lundbeck | Meals · 2025-03-06 | Rexulti | $28 |
| Janssen Pharmaceuticals | Meals · 2025-02-18 | Spravato | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-11 | Caplyta | $28 |
| Lundbeck | Meals · 2025-02-05 | Rexulti | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-21 | Cobenfy | $24 |
| Abbvie | Meals · 2025-01-16 | Vraylar | $28 |
| Janssen Pharmaceuticals | Meals · 2025-01-08 | Spravato | $29 |
See earlier years (2024, 2023)
2024: $297
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $148 | 6 payments
|
| Janssen Pharmaceuticals | Spravato | $73 | 3 payments
|
| Abbvie | Vraylar | $49 | 2 payments
|
| Lundbeck | Rexulti | $27 | 1 payment
|
2023: $118
| Janssen Pharmaceuticals | Spravato | $44 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $32 | 1 payment
|
| Abbvie | Vraylar | $26 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $16 | 1 payment
|
Professional record
- NPI
- 1942788120
- Licence
- CA 95109100, CA NP95012645, PA RN748996, PA SP025467
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 3131 Walnut St Apt 443, Philadelphia, PA, 19104
- NPI first listed
- 2018-07-31
- NPI last updated
- 2022-11-14
- NPI record certified
- 2022-11-14
This is when the NPI record was last certified, not a medical board exam.